Table 3.
Hematological malignancies (N = 48) | Breast cancer (N = 233) | Other solid tumors (N = 105) | Total (N = 386) | ||
---|---|---|---|---|---|
Prior chemotherapy, n (%) | 32 (66.7) | 70 (30.0) | 62 (59.0) | 164 (42.5) | |
Number of prior chemotherapy regimens, n (%) | 0 | 3 (6.3) | 2 (0.9) | 1 (1.0) | 6 (1.6) |
1 | 14 (29.2) | 43 (18.5) | 33 (31.4) | 90 (23.3) | |
2 | 4 (8.3) | 6 (2.6) | 12 (11.4) | 22 (5.7) | |
3 | 4 (8.3) | 7 (3.0) | 8 (7.6) | 19 (4.9) | |
4 | 2 (4.2) | 3 (1.3) | 1 (1.0) | 6 (1.6) | |
5 | 1 (2.1) | 1 (0.4) | 1 (1.0) | 3 (0.8) | |
6 | 0 | 3 (1.3) | 2 (1.9) | 5 (1.3) | |
8 | 1 (2.1) | 2 (0.9) | 0 | 3 (0.8) | |
9 | 1 (2.1) | 1 (0.4) | 0 | 2 (0.5) | |
60 | 0 | 0 | 1 (1.0) | 1 (0.3) | |
Not recorded | 18 | 165 | 46 | 229 |